A role for protein kinase C in arachidonate mobilization was demonstrated. Treatment of rat platelets with phorbol myristate acetate (PMA) or the diacylglycerol l-oleoyl-2-acetylglycerol increased the transfer rate of arachidonate (AA) from phosphatidylcholine to phosphatidylethanolamine and stimulated AA release. The transfer dose-dependently induced by PMA was inhibited by staurosporine. Ether phospholipids were the acceptors of AA in these stimulated transfer reactions. Membrane-bound protein kinase C activity was enhanced by PMA, and this increase was inhibited by staurosporine. AA transfer between phospholipids is due to the action of polyunsaturated-fatty-acid-specific transacylases. For this purpose, transacylase activities were assayed in cell-free systems from PMA-treated platelets. We observed that the CoA-independent transacylase activity was modulated in parallel to AA transfer as a function of PMA concentration. Taken together, the data show that protein kinase C activation might promote the mobilization of AA in platelets through the enhancement of CoA-independent transacylase activity.
INTRODUCTION
Activation ofarachidonate (AA) release is currently considered as the principal mechanism for stimulation of eicosanoid synthesis. Platelets respond to a variety of agonists by rapidly releasing AA from cellular phospholipids, where it is predominantly esterified. However, the mechanisms which control the AA release are not completely understood. Receptor occupancy induces phosphoinositide hydrolysis by phospholipase C, promoting the formation of the intracellular messengers inositol 1,4,5-trisphosphate and 1,2-diacylglycerol, which are responsible for the release of intracellular Ca2+ stores and the activation of protein kinase C respectively [1, 2] . These early events could be responsible for AA mobilization from the major classes of phospholipids. Previous studies have shown that, in platelets [3] [4] [5] [6] , this mobilization involves AA transfer from diacyl-sn-glycero-3-phosphocholine (diacyl-GPC) to diacyl and ether phospholipids, together with AA release. Moreover, AAspecific transacylation reactions were demonstrated in various cell membranes [7] [8] [9] [10] [11] [12] . Since phospholipase A2 is a Ca2+-dependent enzyme and Ca2+ ionophores are effective releasers of AA, phospholipase A2 has been thought to play a major role in controlling AA release. Halenda et al. [13, 14] have shown that the active phorbol esters potentiate AA release induced by the Ca2+ ionophore A23187 in platelets, and this potentiation has been interpreted in terms of activating phospholipase A2 by the protein kinase C system. However, phorbol 12-myristate 13-acetate (PMA) alone, which does not mobilize Ca2+ [15, 16] , is able to release AA [17] . Thus factors other than phospholipase A2 activation, such as inhibition of AA re-incorporation [18] or stimulation of transacylase reactions, might be involved in the protein kinase C-dependent AA release. Here, we showed that PMA alone was able to induce AA mobilization in rat platelets and that this mobilization might be achieved through modulation of CoA-independent transacylase activity.
MATERIALS AND METHODS Materials
1 ,2-Dioleoyl-sn-glycero-3-phospho [2-14C] 10 mM-Tris/HCI, pH 8.0, and 5 mM-Ca2+ for 60 min. Specific radioactivity of the lyso-compound purified on a silicic acid column was 7 mCi/mmol.
The following chemicals were purchased from the companies indicated in parentheses: I-oleoyl-2-acetylglycerol (OAG) and I-alkyl-2-lyso-GPC (Serdary, Ontario, Canada), staurosporine and bee venom phospholipase A2 (Boehringer, Mannheim, Germany), gelatin powder (Merck, Darmstadt, Germany). CoA, ATP, histone type III, egg phosphatidylethanolamine, phosphatidylserine, 1,2-diolein, PMA, 4-phorbol 12,13-didecanoate and fatty-acid-free BSA were from Sigma.
AA transfer and lipid analysis
Platelets from 200-250 g Wistar rats were isolated by the method of Ardlie et al. [19] in Tyrode buffer, pH 6.5, containing 0.25 % gelatin as previously described [4] . [ 65°C)/diethyl ether/acetic acid, (90:30: 1, by vol.). The alkyl, alkenyl and diacyl classes of phosphatidylethanolamine and phosphatidylcholine were resolved after conversion into glycerobenzoate derivatives as described by Blank et al. [21] and previously [6] .
Assay of enzymes Platelets treated with phorbol esters for 2 or 30 min without or with staurosporine and control platelets were, immediately centrifuged, washed and resuspended (4 x I0O platelets/ml) in Tris buffer, pH 6.5, containing 0.2 mM-EDTA. The platelets were then sonicated twice for 20 s each using a microprobe. These broken platelets were assayed for transacylase and protein kinase C activities.
Protein kinase C. The sonicated platelets were centrifuged at 100000 g for 60 min at 4 'C, and protein kinase C was assayed as in [22] . Briefly, the membrane-bound protein kinase C was solubilized by treating the particulate fraction with 0.3 % Triton X-100 in 20 mM-Tris/HCI buffer, pH 7.5, containing 2 mm-EGTA, 2 mM-EDTA, 50 mM-mercaptoethanol and 2 mMphenylmethanesulphonyl fluoride for 60 min at 4 'C. The nonsolubilized material was removed by centrifugation at 100000 g for 60 min at 4 'C. The supernatant from this step was purified by DEAE-cellulose column chromatography performed at 4 'C, and the membrane-bound protein kinase C fraction was eluted with the previous buffer containing 120 mM-NaCl. Protein kinase C activity was immediately assayed in a total volume of 0.1 ml of 40 mM-Hepes buffer, pH 7.4, containing 8 30°C, the reaction was stopped by retaining histone on ionexchange filters (Whatman P81). The filters were washed successively with 1 % H3P04, water, acetone and diethyl ether. The filters were dried and the radioactivity was counted. Protein kinase C activity was determined as the incorporation of 32P (nmol/min per mg of protein) into histone in the presence of Ca2+, phosphatidylserine and diolein minus the incorporation in the absence of these activators.
Transacylases. CoA-independent and CoA-dependent transacylases were evaluated by the acylation rate of labelled 1-ether and I-acyl lyso-derivatives in the absence and in the presence of 50 ,#M-CoA. The incubation mixture contained the lyso-derivatives, 0.
in Tyrode buffer, added to platelet suspensions. After 10 min at 37°C, the reaction was stopped by adding chloroform/methanol (1: 2, v/v). The lipids were extracted as described above, and the acylated compound was separated from the lyso-derivative by t.l.c. in chloroform/methanol/water (30:20:3, by vol.). Radioactive lipid spots were scraped from the plate and counted for radioactivity. platelets, newly incorporated AA was slowly transferred from phosphatidylcholine to phosphatidylethanolamine, as previously observed [23] . Part of the labelled AA was also released from phospholipids. PMA and OAG treatment increased the rate of AA transfer and release (Fig. 1) Vol. 280 Table 3 . Stimulation of CoA-independent transacylase by PMA Sonicates from control, PMA-and PMA+staurosporine-treated platelets were prepared and incubated with hexadecyl-lyso-GPC or acyl-lyso-GPE added as a sonicated dispersion as described in the Materials and methods section. Transacylase activities were assayed by measuring the acylation rate of the lyso-derivatives in the absence or the presence of 50 1sM-CoA (CoA-independent and CoA-dependent transacylase respectively).
RESULTS

Acylation (%)
CoA-independent transacylase CoA-dependent transacylase
Hexadecyl-lyso-GPC Acyl-lyso-GPE Hexadecyl-lyso-GPC Acyl-lyso-GPE Control PMA ( [PMA] (nM) Fig. 4 . CoA-independent transacylase activity as a function of PMA CoA-independent transacylase activity was assayed with hexadecyllyso-GPC as substrate as in Table 3 . The data are means+ S.D. of one experiment performed in duplicate.
Acyl-AA-GPC Alkyl-AA-GPC Acyl-AA-GPE Alkyl-AA-GPE Alkenyl-AA-GPE also assayed in PMA-treated platelets and did not prevent AA redistribution from phosphatidylcholine to phosphatidylethanolamine ( Table 1 ). The effect of PMA on AA mobilization was dose-dependent (Fig. 2) . A maximum transfer rate between phosphatidylcholine and phosphatidylethanolamine was observed between 4 nM-and 8 nM-PMA. To ensure the maximum effect, 20 nM-PMA was routinely used in all experiments. We have previously observed that AA was not transferred from or to phosphatidylinositol in resting platelets [23] . In our incubation conditions, PMA did not induce any change in the labelling of phosphatidylinositol (Fig. 2) . Thus PMA did not promote phosphatidylinositol bisphosphate hydrolysis, as previously described [24, 25] , nor did it elicit AA redistribution from or to phosphatidylinositol.
Effect of staurosporine on PMA-induced AA mobilization Staurosporine has been shown to be a potent protein kinase C inhibitor in human platelets [26] . When added to PMA-treated rat platelets, staurosporine inhibited by 40 60% the PMAinduced AA transfer and almost abolished the AA release induced by PMA (Fig. 3) . Staurosporine had no effect on AA transfer and release observed in resting platelets.
Activation of protein kinase C from rat platelets Protein kinase C activity was measured in the cytosol and in a Triton X-100 extract from the particulate fraction partially purified by DEAE-cellulose ion-exchange column chromatography. In PMA-treated platelets, protein kinase C activity found in the particulate fraction increased by 64 % as compared with control platelets, and this increase was inhibited by staurosporine (Table 2) .
PMA-induced stimulation of CoA-independent transacylase activities
To examine the regulation of transacylase activities by PMA, sonicated platelets prepared from control, PMA-and PMA + staurosporine-treated platelets were assayed for transacylase activities by measuring the acylation rate of lysoderivatives. The acylation rates of ether and acyl lyso-derivatives in the absence and in the presence of CoA were compared (Table  3) . Hexadecyl-lyso-GPC was a better substrate than acyl-lyso-GPE in the CoA-independent reaction. The opposite was observed in the CoA-dependent reaction. After 30 min treatment with 20 nM-PMA, the CoA-independent acylations of hexadecyllyso-GPC and acyl-lyso-GPE were increased by 35 + 11 % and 40 + 9 % respectively, and this increase was considerably decreased by 1 ,uM-staurosporine. CoA-dependent acylation of either lyso-compound was not modified by PMA treatment of the platelets.
These experiments demonstrate that PMA stimulates specifically CoA-independent transacylases. The acylation rate of hexadecyl-lyso-GPC dose-dependently increased as a function of PMA and was maximum around 10 nM-PMA (Fig. 4) PMA + staurosporine-treated platelets, and then choline-and ethanolamine-containing phospholipids were separated, as well as their diacyl and ether subclasses. PMA increased AA transfer from diacyl-GPC to alkylacyl-GPC and to alkenylacyl-GPE. The PMA-induced AA transfer to ether phospholipids was inhibited by staurosporine (Table 4) .
DISCUSSION
Transfer reactions have been demonstrated in a number of resting cells [27] [28] [29] , including platelets [23] . In receptor-dependent platelet activation, the liberation of AA from esterified pools is correlated with an increase in AA transfer between phospholipids, mainly from diacyl-GPC to ether phospholipids [3, 4] . Furthermore, we have shown that AA was not released directly from diacyl-GPC; it was first transferred to other phospholipids, to be released subsequently [6] . Since protein kinase C activation has been involved in AA release, it was decided to investigate whether protein kinase C activation also promoted an increase in AA transfer between phospholipids.
PMA and OAG, two well-known activators of protein kinase C [30, 31] , increased the transfer rate of AA from phosphatidylcholine to phosphatidylethanolamine as well as AA liberation from esterified pools. Reacylation as a possible control mechanism for the cellular levels of free AA has been shown in macrophages [18] , in smooth-muscle cells [32] and in platelets [33] . However, the acyl-CoA acyltransferase is highly specific for lysophosphatidylcholine and lysophosphatidylinositol in platelets [34, 35] . Therefore, the decrease in phosphatidylcholine labelling and the absence of change in labelling of phosphatidylinositol are not likely to account for the sequential action of phospholipase A2 and acyl-CoA acyltransferase. Moreover, an excess of unlabelled AA did not modify AA transfer induced by PMA, clearly showing that AA was not released and reincorporated, but was directly transferred from phosphatidylcholine to phosphatidylethanolamine. We have previously shown that inhibition of cyclo-oxygenase and lipoxygenase with compound BW 755C did not modify the AA transfer induced by thrombin [6] . This compound, or trapping of free AA by fattyacid-free BSA, did not change the AA transfer elicited by PMA. These results demonstrate that oxygenated derivatives of AA or free AA had no effect on the transfer reactions.
Thus, in addition to potentiating the effect of Ca2+ ionophores on AA release [13, 14] , PMA by itself is able to induce AA mobilization in platelets. However, this process is slow as compared with AA release elicited by the Ca2+ ionophore A23 187 plus PMA, and it was not detected previously in platelets [14] , in contrast with cultured cells [17] .
A PMA concentration of 10 nm elicited maximal AA mobilization, which corresponded to the dose inducing maximal protein kinase C activation in human platelets [30] . This PMA concentration effectively increased the activity of rat platelet membrane-associated protein kinase C. The phorbol-diesterinduced AA transfer and release were inhibited by the protein kinase C inhibitor staurosporine [26] . The inhibition observed in the presence of staurosporine was between 70 and 90 % for both AA transfer and protein kinase C. Thus we can conclude that protein kinase C activation promotes an increase in AA transfer rate from phosphatidylcholine to phosphatidylethanolamine.
AA transfer between phospholipids is assumed to depend on polyunsaturated-fatty-acid-specific transacylases [8] [9] [10] [11] , which are induced in cell-free systems by addition of lyso-derivatives, which can be produced through the action of phospholipase A2. Since phospholipase A2 is a Ca2+-dependent enzyme and protein kinase C interacts with Ca2+ in a synergistic manner to increase AA release, protein kinase C has been thought to increase phospholipase A2. In PMA-activated mesangial cells, an increase in the phospholipase A2 recovered in a cell-free extract was observed [36] . Here we show that the mobilization of AA induced by protein kinase C activators in platelets might be achieved through, the enhancement of CoA-independent transacylase activity.
The acylation rate of alkyl-lyso-GPC by cell-free fractions was increased by platelet pretreatment with PMA. This increase correlated closely with the activation of AA transfer in intact cells as a function of PMA concentration. Transacylation of this ether phospholipid, which is the precursor of the bioactive lipid Paf-acether, is essentially CoA-independent [9] [10] [11] , whereas the transacylation of acyl phospholipids is primarily CoA-dependent [12] . Therefore we used acyl-lyso-GPE to demonstrate that only CoA-independent transacylase was increased after PMA treatment. Staurosporine, which inhibited PMA-induced protein kinase C activation, also inhibited AA transfer and CoAindependent transacylase activity induced by PMA. Moreover, using prelabelled platelets, we showed that PMA induced the transfer of AA to the ether phospholipids, alkylacyl-GPC and alkenylacyl-GPE. Such transfers are involved in AA release, since AA is never directly released from diacyl-GPC during receptor-mediated platelet activation [6] . AA might be funnelled through alkylacyl-GPC and/or ethanolamine-containing phospholipids [6, 37] . Thus, when platelets are stimulated with an agonist that increases the level of diacylglycerol, protein kinase C is in turn activated. This activation might play an important role in the mobilization of AA from major sources of AA, which are the ethanolamine-and choline-containing phospholipids, by stimulating CoA-independent transacylases. Taken together, our data demonstrate that CoA-independent transacylase might control both AA release and lysophospholipid formation, and thus participate in the synthesis of bioactive lipids such as Pafacether and AA derivatives.
